Inhaled or IV? study tests best route for mucus drug in lung disease
NCT ID NCT07293884
First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study tests whether breathing in N-acetylcysteine (a mucus-thinning drug) works better than getting it through a vein for people with bronchiectasis, a lung condition that causes thick mucus. About 70 adults hospitalized with a flare-up will be randomly assigned to one of the two methods. The goal is to see which route makes mucus easier to cough up and reduces breathing difficulty.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHEICTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.